Clinical Trials List
2021-07-01 - 2025-12-31
Phase II
Recruiting4
ICD-10C53.0
Malignant neoplasm of endocervix
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9180.0
Malignant neoplasm of endocervix
-
Trial Applicant
Merck Sharp & Dohme (I.A.) LLC
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Shang-Yin Wu Division of Hematology & Oncology
- Cheng-Yang Chou Division of Obstetrics & Gynecology
- Yao-Lung Kuo Division of General Surgery
- Wei-Pang Chung Division of Hematology & Oncology
- 劉奕廷 Division of Hematology & Oncology
- 顏志傑 Division of Hematology & Oncology
- Wen-Pin Su Division of Hematology & Oncology
- Keng-Fu Hsu Division of Obstetrics & Gynecology
- 簡世杰 Division of General Internal Medicine
- 外科部 未分科
- 吳珮瑩 Division of Obstetrics & Gynecology
- Chien-Jui Huang Division of General Internal Medicine
- Yu-Fang Huang Division of Obstetrics & Gynecology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 林宗哲 Division of Hematology & Oncology
- TSUNG-HAO LIU Division of Hematology & Oncology
- 張端瑩 Division of Hematology & Oncology
- HUAI-CHENG HUANG Division of Hematology & Oncology
- 戴依柔 Division of Obstetrics & Gynecology
- 梁逸歆 Division of Hematology & Oncology
- 黃柏翔 Division of Hematology & Oncology
- Chiun Hsu Division of Hematology & Oncology
- 呂理駿 Division of Hematology & Oncology
- YEN-SHEN LU Division of Hematology & Oncology
- Hsiang-Fong Kao Division of Hematology & Oncology
- YING-CHENG CHIANG Division of Obstetrics & Gynecology
- 陳國興 Division of Hematology & Oncology
- 廖斌志 Division of Hematology & Oncology
- Kun-Huei Yeh Division of Hematology & Oncology
- YU-YUN SHAO Division of Hematology & Oncology
- JHE-CYUAN GUO Division of Hematology & Oncology
- WEI-LI MA Division of Hematology & Oncology
- 陳宇立 Division of Obstetrics & Gynecology
- CHI-HAU CHEN CHI-HAU CHEN Division of Obstetrics & Gynecology
- FU-JEN HSUEH Division of Hematology & Oncology
- 林季宏 Division of Hematology & Oncology
- Ann-Lii Cheng Division of Hematology & Oncology
- Ying-Chun Shen Division of Hematology & Oncology
- TA-CHEN HUANG Division of Hematology & Oncology
- Wei-Wu Chen Division of Hematology & Oncology
- Wen-Fang Cheng Division of Obstetrics & Gynecology
- 童寶玲 Division of Obstetrics & Gynecology
- Yu-Chieh Tsai Division of Hematology & Oncology
- 陳怡君 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Jen-Shi Chen Division of Hematology & Oncology
- Ming-Mo Hou Division of Hematology & Oncology
- Ting-Chang Chang Division of Obstetrics & Gynecology
- Yun-Hsin Tang Division of Obstetrics & Gynecology
- Cheng-Lung Hsu Division of Hematology & Oncology
- 周宏學 Division of Obstetrics & Gynecology
- Wen-Chi Chou Division of Hematology & Oncology
- Chyong-Huey Lai Division of Obstetrics & Gynecology
- Hsien-Kun Chang Division of Hematology & Oncology
- Min-Yu Chen Division of Obstetrics & Gynecology
- 陳威君 Division of Obstetrics & Gynecology
- 張献崑 Division of Hematology & Oncology
- Hung-Chih Hsu Division of Hematology & Oncology
- Yung-Chang Lin Division of Hematology & Oncology
- Huei-Jean Huang Division of Obstetrics & Gynecology
- Cheng-Tao Lin Division of Obstetrics & Gynecology
- 張淑涵 Division of Obstetrics & Gynecology
- 黃文冠 Division of Hematology & Oncology
- Tsai-Sheng Yang Division of Hematology & Oncology
- Hung-Ming Wang Division of Hematology & Oncology
- 黃寬仁 Division of Obstetrics & Gynecology
- Angel Chao Division of Obstetrics & Gynecology
- HSIU-JUNG TUNG Division of Obstetrics & Gynecology
- Po-Jung Su Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
50 participants
-
Global
610 participants
